Drug Markets/Ergocalciferol

Ergocalciferol

4 NDCs across 4 manufacturers|4 Generic,0 Brand

Ergocalciferol is used to treat hypoparathyroidism, hypophosphatemia and rickets, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982.

Ergocalciferol is available as 4 NDCs from 4 manufacturers (4 generic, 0 brand), with NADAC prices from $0.11 to $0.11 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

4

competing in market

Price Spread

$0.11 – $0.11

per EA

7d Activity

40 flat

avg -1.6% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Ergocalciferol used to treat?

Ergocalciferol is used to treat hypoparathyroidism, hypophosphatemia and rickets, per the National Library of Medicine's MED-RT classification.

When did Ergocalciferol become available as a generic?

FDA approved the first generic Ergocalciferol (ANDA) on Jan 1, 1982.

How many Ergocalciferol products are on the market?

The Ergocalciferol drug market contains 4 NDCs from 4 manufacturers — 4 generic and 0 brand products.

What is the price range for Ergocalciferol?

NADAC reference prices for Ergocalciferol range from $0.1136 to $0.1136 per EA.

Which manufacturers make Ergocalciferol?

4 manufacturers list Ergocalciferol in NADAC. Ranked by number of NDCs, the largest are AvPAK (1), Chartwell RX LLC (1), Strides Pharma Inc. (1), Bionpharma Inc. (1).

How has the price of Ergocalciferol changed recently?

Over the past 7 days, 0 Ergocalciferol NDCs rose and 4 fell, with a market-wide average change of -1.6%.